Reported Use of IV-Tissue Plasminogen Activator (IV-TPA) for Acute Ischemic Stroke (AIS) Worldwide: A Systematic Review

被引:0
|
作者
Mittal, Manoj [1 ]
Berkowitz, Aaron [2 ]
McLane, Hannah [3 ]
Shen, Gordon [4 ]
Muralidharan, Rajanandini [5 ]
Lyons, Jennifer [6 ]
Shinohara, Russell [7 ]
Shuaib, Ashfaq [8 ]
Mateen, Farrah [6 ]
机构
[1] Mayo Clin, Rochester, MN USA
[2] Harvard Univ, Boston, MA 02115 USA
[3] Brown Univ, Providence, RI 02912 USA
[4] Univ Calif Berkeley, Berkeley, CA 94720 USA
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] Johns Hopkins Univ, Baltimore, MD USA
[7] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[8] Univ Alberta, Div Neurol, Edmonton, AB, Canada
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IN72001
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Reported Use of IV-Tissue Plasminogen Activator (IV-TPA) for Acute Ischemic Stroke (AIS) Worldwide: A Systematic Review
    Mittal, Manoj
    Berkowitz, Aaron
    McLane, Hannah
    Shen, Gordon
    Muralidharan, Rajanandini
    Lyons, Jennifer
    Shinohara, Russell
    Shuaib, Ashfaq
    Mateen, Farrah
    [J]. NEUROLOGY, 2013, 80
  • [2] IV-Tissue Plasminogen Activator (IV-TPA) for Acute Ischemic Stroke (AIS) in HIV plus Adults
    Mateen, Farrah J.
    Sweeney, Elizabeth M.
    Thakur, Kiran T.
    Lyons, Jennifer L.
    Smith, Bryan R.
    Cervantes-Arslanian, Anna M.
    Shinohara, Russell T.
    Schwamm, Lee H.
    Elkind, Mitchell S. V.
    Willey, Josh Z.
    [J]. ANNALS OF NEUROLOGY, 2013, 74 : S9 - S9
  • [3] Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke
    Berkowitz, Aaron L.
    Mittal, Manoj K.
    McLane, Hannah C.
    Shen, Gordon C.
    Muralidharan, RajaNandini
    Lyons, Jennifer L.
    Shinohara, Russell T.
    Shuaib, Ashfaq
    Mateen, Farrah J.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2014, 9 (03) : 349 - 355
  • [4] Safety and Feasibility of Intravenous Tissue Plasminogen Activator (IV-tPA) in Acute Ischemic Stroke Patients, Update on Tabriz Thrombolytic Therapy on Acute Ischemic Stroke (T3AIS) Project
    Hokmabadi, Sadeghi E.
    Farhoudi, M.
    Oskouei, Savadi D.
    Taheraghdam, A.
    Hashemilar, M.
    Yazdchi, M.
    Mehrvar, K.
    Ghiasi, Rikhtegar R.
    Hassasi, R.
    Farzi, M. A.
    Aliyar, H.
    Mehdizadeh, E.
    Tamar, Hasaneh S.
    Hadavibavili, M.
    [J]. CEREBROVASCULAR DISEASES, 2016, 42 : 46 - 46
  • [5] IV-tPA use for acute stroke in California
    Birbeck, G
    Cui, XP
    Vickrey, B
    [J]. STROKE, 2000, 31 (11) : 2883 - 2883
  • [6] Cleveland community experience with intravenous tissue plasminogen activator (IV-tPA): Patient selection
    Hammer, MD
    Katzan, IL
    Furlan, AJ
    Abou-Chebl, A
    Hixson, E
    [J]. STROKE, 2002, 33 (01) : 386 - 386
  • [7] INFORMED DECISION MAKING IN THE TREATMENT OF ISCHEMIC STROKE WITH IV-TPA
    Guhwe, M.
    Napier, S.
    Dodds, J.
    Chancy, S.
    Chioffi, S.
    Graffagnino, C.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 62 - 62
  • [8] Iv Tpa For Acute Ischemic Stroke In The Setting Of Intracranial Tumor: A Systematic Review
    Moran, Caitlin E.
    Rubin, Mark N.
    [J]. STROKE, 2022, 53
  • [9] IV tissue plasminogen activator use in acute stroke What are neurologists thinking?
    Boissy, Adrienne R.
    [J]. NEUROLOGY, 2013, 81 (13) : 1110 - 1111
  • [10] Proposal for safe use of IV-tPA in an acute stroke scenario in the pregnant patient
    Donato, J.
    Favate, A.
    Kim, N.
    [J]. CEREBROVASCULAR DISEASES, 2018, 45 : 297 - 297